BEST-CLI试验评估显示:吸烟的慢性肢体威胁性缺血患者行腹股沟下旁路术可能具有潜在优势
BEST-CLI试验按吸烟状态分层分析发现,当前吸烟者较非吸烟者MALE发生率更高(HR 1.27)但全因死亡更低(HR 0.80);在开放手术组,当前吸烟者全因死亡更低(HR 0.74)且MALE无显著差异;在血管内治疗组,当前吸烟者踝上截肢(HR 1.51)和MALE(HR 1.33)发生率更高。
要点
- 当前吸烟者较非吸烟者MALE风险更高(HR 1.27),但全因死亡风险更低(HR 0.80)。
- 开放旁路组中当前吸烟者全因死亡更低(HR 0.74),MALE无显著差异(HR 1.18)。
- 血管内治疗组中当前吸烟者踝上截肢(HR 1.51)和MALE(HR 1.33)风险更高。
核心结论
- 当前吸烟者在BEST-CLI试验中肢体结局更差,接受血管内血运重建者校正后MALE和踝上截肢发生率更高,而当前吸烟对开放手术旁路患者的MALE无影响。
研究设计与样本
- BEST-CLI为前瞻性随机试验,纳入适合开放或血管内干预的慢性肢体威胁性缺血患者,随机分配至血管内干预(ENDO)或开放手术旁路(OPEN),并按当前吸烟者(CS)与非吸烟者(NS,包括既往吸烟者和从不吸烟者)分层。
- 患者接受单段大隐静脉旁路(n=621)、替代管道旁路(n=236)或血管内手术(n=923),共有641例当前吸烟者和1137例非吸烟者;采用多变量Cox回归模型,以非吸烟者为参照组。
主要发现
- 在ENDO或OPEN联合队列中,当前吸烟者较非吸烟者MALE发生率更高(HR 1.27;95%CI 1.05-1.55;P=.02),但全因死亡更低(HR 0.80;95%CI 0.66-0.97;P=.02)。
- 在OPEN组中,当前吸烟者较非吸烟者全因死亡更低(HR 0.74;95%CI 0.56-0.98;P=.04),MALE无显著差异(HR 1.18;95%CI 0.85-1.63;P=.34)。
- 在ENDO组中,当前吸烟者较非吸烟者踝上截肢(HR 1.51;95%CI 1.04-2.19;P=.03)和MALE(HR 1.33;95%CI 1.04-1.69;P=.02)发生率更高。
- 全队列亚组分析中,既往吸烟者较从不吸烟者再干预增加24%(P=.05),当前吸烟者较从不吸烟者再干预增加27%(P=.04)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Smoking is an established risk factor in many pathologies of the cardiovascular system. The Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial affords an in-depth evaluation into the effect of smoking on patients with chronic limb-threatening ischemia (CLTI). BEST-CLI's prospective, randomized design evaluated outcomes in patients suitable for both open or endovascular intervention and randomized patients between endovascular intervention (ENDO) vs open surgical bypass (OPEN). The outcomes are reported stratified by smoking status. METHODS: In the BEST-CLI trial, patients were stratified by current smokers (CS) and nonsmokers (NS), which included both previous smokers or never smokers. Endpoints at 4 years include the primary trial outcomes (major adverse limb events [MALE] or all-cause death), as well as above-ankle amputation, all-cause death, major or minor reintervention, major adverse cardiac events (MACE), MALE, and MALE or perioperative death. Multivariable Cox regression models were created with NS serving as the reference group. RESULTS: Patients received bypass using single-segment saphenous vein (n = 621), bypass using alternative conduits (n = 236), or endovascular procedures (n = 923). There were 641 CSs and 1137 NSs. In the combined cohort of patients receiving ENDO or OPEN, CS status was associated with a higher rate of MALE (hazard ratio [HR], 1.27; 95% confidence interval [CI], 1.05-1.55; P = .02) but a lower rate of all-cause death (HR, 0.80; 95% CI, 0.66-0.97; P = .02) when compared with NS status. In the OPEN group, CSs had a lower rate of all-cause death (HR, 0.74; 95% CI, 0.56-0.98; P = .04) than NSs and no significant difference in MALE (HR, 1.18; 95% CI, 0.85-1.63; P = .34). In the ENDO group, CSs had a higher rate of above-ankle amputation (HR, 1.51; 95% CI, 1.04-2.19; P = .03) and MALE (HR, 1.33; 95% CI, 1.04-1.69; P = .02). Additionally, on subset analysis of the entire cohort, it was found that, when comparing prior smokers to never-smokers, there was a 24% increase in reintervention (P = .05), and when comparing CSs to never smokers, there was a 27% increase in reintervention (P = .04). CONCLUSIONS: CSs had worse limb outcomes in the BEST-CLI trial. CSs undergoing endovascular revascularization had higher rates of MALE and above-ankle amputations following adjustment. Current smoking did not impact MALE in patients with CLTI undergoing open surgical bypass.
引用
- Barleben AR, Patel RJ, Farber A, et al. An assessment of the BEST-CLI Trial demonstrates that infrainguinal bypass offers a potential advantage in smokers with chronic limb-threatening ischemia. J Vasc Surg. 2025. PMID: 39984143. doi:10.1016/j.jvs.2025.02.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。